Supression of germline editing is a tragedy
Harder to charge insurance $10M for an embryo that isn't even a "human" yet
If germline editing ever does somehow pass an ethics & safety review, pharma co's will find a way to kill it
Harder to charge insurance $10M for an embryo that isn't even a "human" yet
If germline editing ever does somehow pass an ethics & safety review, pharma co's will find a way to kill it
Loading…
Subscribe to get new essays in your inbox.
On Sayim & Cavanagh (https://www.frontiersin.org/articles/10.3389/fnhum.2011.00118/abstract) Perspective on line drawings, how they are significant: --> via learned neural codes that spark understanding of an object (the…
At treehacks, sam altman said that stanford is becoming a "negative signal" for raising money he talked about how, historically, stanford undergrad had an advantage and was "very well connected to the whole... VC machine…
market seems to think hims is cooked b/c margins on non-glp1 services are low this is true however, they are not as bad as people think from my experience working in d2c pharmacy space, i know gross margins working w/ a …